M.M. Ewing

627 total citations
23 papers, 488 citations indexed

About

M.M. Ewing is a scholar working on Immunology, Cancer Research and Surgery. According to data from OpenAlex, M.M. Ewing has authored 23 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in M.M. Ewing's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Protease and Inhibitor Mechanisms (5 papers). M.M. Ewing is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Protease and Inhibitor Mechanisms (5 papers). M.M. Ewing collaborates with scholars based in Netherlands, United States and France. M.M. Ewing's co-authors include Paul H.A. Quax, J. Wouter Jukema, Colin Ratledge, Margreet R. de Vries, Jacco C. Karper, Johan Kuiper, Hetty C. de Boer, Ramon Arens, Rob C. M. de Jong and Hendrika A. B. Peters and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

M.M. Ewing

22 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.M. Ewing Netherlands 10 202 195 90 72 48 23 488
Yuan Hu China 12 222 1.1× 289 1.5× 69 0.8× 61 0.8× 36 0.8× 19 556
Yifeng Guo China 12 145 0.7× 137 0.7× 48 0.5× 65 0.9× 40 0.8× 37 600
Turid M. Pedersen Norway 14 213 1.1× 177 0.9× 66 0.7× 71 1.0× 78 1.6× 24 678
Lina Paola D’Atri Argentina 13 226 1.1× 376 1.9× 46 0.5× 56 0.8× 48 1.0× 16 753
Athanasios Ziogas Germany 14 142 0.7× 237 1.2× 104 1.2× 23 0.3× 32 0.7× 16 573
Helena Cucak Denmark 9 134 0.7× 390 2.0× 93 1.0× 60 0.8× 75 1.6× 13 598
Giovanni Luca Scaglione Italy 16 308 1.5× 103 0.5× 62 0.7× 64 0.9× 72 1.5× 55 677
Fionnuala B. Hickey Ireland 14 252 1.2× 186 1.0× 47 0.5× 55 0.8× 50 1.0× 23 597
Natalia K. Botelho Australia 12 217 1.1× 203 1.0× 167 1.9× 98 1.4× 88 1.8× 16 646

Countries citing papers authored by M.M. Ewing

Since Specialization
Citations

This map shows the geographic impact of M.M. Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.M. Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.M. Ewing more than expected).

Fields of papers citing papers by M.M. Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.M. Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.M. Ewing. The network helps show where M.M. Ewing may publish in the future.

Co-authorship network of co-authors of M.M. Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of M.M. Ewing. A scholar is included among the top collaborators of M.M. Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.M. Ewing. M.M. Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vos, Nicola S., René J. van der Schaaf, Giovanni Amoroso, et al.. (2023). EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries. International Journal of Cardiology. 386. 24–29. 4 indexed citations
2.
Vries, Margreet R. de, M.M. Ewing, Rob C. M. de Jong, et al.. (2020). Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases. Journal of Internal Medicine. 290(1). 141–156. 14 indexed citations
3.
Jong, Rob C. M. de, M.M. Ewing, Margreet R. de Vries, et al.. (2017). The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development. PLoS ONE. 12(10). e0185820–e0185820. 35 indexed citations
4.
Ewing, M.M., Jacco C. Karper, Rob C. M. de Jong, et al.. (2013). T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. International Journal of Cardiology. 168(3). 1965–1974. 106 indexed citations
5.
Bastiaansen, A.J.N.M., M.M. Ewing, Hetty C. de Boer, et al.. (2013). Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 33(8). 1902–1910. 51 indexed citations
6.
Karper, Jacco C., M.M. Ewing, Margreet R. de Vries, et al.. (2013). TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation. PLoS ONE. 8(7). e67923–e67923. 27 indexed citations
7.
Ewing, M.M., Jacco C. Karper, Margreet R. de Vries, et al.. (2013). Optimized anti-phosphorylcholine IgG for therapeutic inhibition of inflammatory vascular disease. European Heart Journal. 34(suppl 1). P5703–P5703. 1 indexed citations
8.
Ewing, M.M.. (2013). Post-interventional atherosclerotic vascular remodeling : preclinical investigation into immune-modulatory therapies. Data Archiving and Networked Services (DANS).
9.
Karper, Jacco C., Saskia C.A. de Jager, M.M. Ewing, et al.. (2013). An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation. Arteriosclerosis Thrombosis and Vascular Biology. 33(12). 2810–2817. 22 indexed citations
10.
Ewing, M.M., Jacco C. Karper, M. Lourdes Sampietro, et al.. (2012). Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice. Atherosclerosis. 221(2). 333–340. 24 indexed citations
11.
Das, I., et al.. (2012). Dosimetric Impact of Gastric and Bowel Air Column in IMRT for Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 84(3). S723–S724. 1 indexed citations
12.
Pettersson, Knut, M.M. Ewing, Margreet R. de Vries, et al.. (2011). Abstract 15644: A Fully Human Monoclonal IgG Phosphorylcholine Antibody Prevents Accelerated Atherosclerosis in Mice. Circulation. 124. 2 indexed citations
13.
Karper, Jacco C., Saskia C.A. de Jager, M.M. Ewing, et al.. (2011). Abstract 14685: RP105, A Cell Surface TLR4 Signaling Regulator, Enhances Atherosclerotic Plaque Formation. Circulation. 124. 253–4. 1 indexed citations
14.
Ewing, M.M., Kim Pettersson, Jacco C. Karper, et al.. (2011). 383 ANNEXIN A5 PREVENTS REACTIVE STENOSIS IN A DOSE-DEPENDENT FASHION: POTENTIAL FOR CLINICAL APPLICATION. Atherosclerosis Supplements. 12(1). 82–82. 1 indexed citations
15.
Ewing, M.M., Jeffrey J. W. Verschuren, M. Lourdes Sampietro, et al.. (2010). Annexin A5: genotypic risk marker for clinical restenosis after percutaneous coronary intervention. European Heart Journal. 31. 803–803. 1 indexed citations
17.
Ewing, M.M., Margreet R. de Vries, Knut Pettersson, et al.. (2010). Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 31(1). 95–101. 76 indexed citations
18.
Bergheanu, Sandrin C., Douwe Pons, Ioannis Karalis, et al.. (2010). Genetic determinants of adverse outcome (restenosis, malapposition and thrombosis) after stent implantation. Interventional Cardiology. 2(2). 147–157. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026